Study suggests iron accumulation plays a central role in senescence and fibrosis

Bris­tol My­ers Squibb is clos­ing a cell ther­a­py R&D site in Cal­i­for­nia as the com­pa­ny im­ple­ments a $1.5 bil­lion cost-cut­ting pro­gram that was an­nounced this

Share this article The EMA has already accepted a marketing application from Valneva under accelerated review for the disease. Image credit: Shutterstock/Iryna Mylinska. Hot on